97-13322. National Emission Standards for Hazardous Air Pollutants, Proposed Rule for Pharmaceuticals Production  

  • [Federal Register Volume 62, Number 98 (Wednesday, May 21, 1997)]
    [Proposed Rules]
    [Page 27707]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-13322]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    
    40 CFR Part 63
    
    [AD-FRL-5828-4]
    
    
    National Emission Standards for Hazardous Air Pollutants, 
    Proposed Rule for Pharmaceuticals Production
    
    AGENCY: U.S. Environmental Protection Agency (U.S. EPA).
    
    ACTION: Extension of public comment period.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The EPA is announcing the extension of the public comment 
    period on the proposed national emission standards for hazardous air 
    pollutants (NESHAP) for pharmaceuticals production (62 FR 15754), which 
    was published on April 2, 1997.
    
    DATES: Written comments must be received on or before July 2, 1997.
    
    ADDRESSES: Submit comments in duplicate if possible to: Air Docket 
    Section (LE-131), Attention: Docket No. A-96-03, U.S. Environmental 
    Protection Agency, 401 M Street, SW, Washington, DC 20460. The EPA 
    requests that separate copies be sent to the appropriate contact person 
    listed below. The docket may be inspected at the above address between 
    8:00 a.m. and 5:30 p.m. on weekdays, and a reasonable fee may be 
    charged for copying.
    
    FOR FURTHER INFORMATION CONTACT: For information concerning the NESHAP, 
    contact Mr. Randy McDonald at (919)541-5402, Organic Chemicals Group, 
    Emission Standards Division (MD-13), U.S. Environmental Protection 
    Agency, Research Triangle Park, NC 27711. For information concerning 
    the effluent limitation guideline pretreatment standards or new source 
    performance standards, contact Dr. Frank Hund at (202) 260-7786, 
    Engineering and Analysis Division (4303), U.S. Environmental Protection 
    Agency, 401 M Street SW., Washington, DC 20406.
    
    SUPPLEMENTARY INFORMATION: In response to a request from the 
    Pharmaceutical Research and Manufacturers of America (PhRMA), EPA is 
    extending the public comment period on the proposed standards from June 
    2, 1997 to July 2, 1997. The EPA agrees with PhRMA that an extension of 
    the comment period will provide for more meaningful, constructive 
    comments on the proposed rule. Having extended the comment period, EPA 
    nonetheless encourages commenters to submit their comments (or as many 
    of their comments as possible) before July 2; this would assist EPA in 
    its considerations of the issues raised. Because the EPA has continued 
    during the comment period to examine the issues outlined in the 
    solicitation of comments section in the preamble of the proposed rule, 
    EPA does not believe the extension of the comment period will disrupt 
    the Agency's schedule for promulgating this regulation.
    
    List of Subjects in 40 CFR Part 63
    
        Environmental protection, Air pollution control, Hazardous 
    substances, Reporting and recordkeeping requirements.
    
        Dated: May 14, 1997.
    Richard Wilson,
    Acting Assistant Administrator for Air and Radiation.
    [FR Doc. 97-13322 Filed 5-20-97; 8:45 am]
    BILLING CODE 6560-50-P
    
    
    

Document Information

Published:
05/21/1997
Department:
Environmental Protection Agency
Entry Type:
Proposed Rule
Action:
Extension of public comment period.
Document Number:
97-13322
Dates:
Written comments must be received on or before July 2, 1997.
Pages:
27707-27707 (1 pages)
Docket Numbers:
AD-FRL-5828-4
PDF File:
97-13322.pdf
CFR: (1)
40 CFR 63